Astrocyte Pharmaceuticals is a clinical-stage drug discovery and development company dedicated to accelerating the recovery and well-being of brain injury patients. Astrocyte is committed to proving the neuro- and cerebroprotective benefits of enhanced mitochondrial energy production in astrocytes, and advancing breakthrough therapeutic agents for treating brain injury resulting from stroke, TBI, concussion, and neurodegenerative disorders such as Alzheimer’s disease.
Astrocyte Pharmaceuticals的外部链接
We’re excited to share our latest advances in brain injury treatment! Learn how we’re advancing neuroprotection for #stroke and #TBI #concussion .
Astrocyte Pharmaceuticals is proud to be leading the way in neuroprotection! Discover how our novel approach could change the future of brain injury care at https://lnkd.in/erugYzyE Jim Lechleiter , Ph D. & Ted Liston
Innovator of the Month!
It's an honor to have Astrocyte Pharmaceuticals and our innovative Connecticut research recognized by Senator Chris Murphy! https://lnkd.in/ewwPSSD7 Ted Liston, Rusty Poe, Ph.D., PMP
New broad-ranging podcast conversation between Astrocyte Pharmaceuticals' CEO William Korinek and Vial's Amy Del Medico - click to learn more about #astrocytes, #neuroprotection and the advancement of new potential treatments!
Explore the fascinating world of neuroprotection and astrocyte science with William Korinek of Astrocyte Pharmaceuticals. Gain insights into the promising future of therapies aiming to safeguard brain function and well-being. Check out the full episode of First in Human wherever you get your podcasts: ??Spotify: https://lnkd.in/gMcFJce4 ??Apple: https://lnkd.in/dxWnKiDa ??YouTube: https://lnkd.in/gF9erExX ??Transcript: https://lnkd.in/gzqybTcZ
Great poster and discussions on innovative serial CSF collection in Phase 1 trials by Lisa Manna, MBA RN and Peter Dogterom at #ASCPT2024 !
Meet with Astrocyte Pharmaceuticals at #ASCPT2024! Astrocyte’s Lisa Manna, MBA RN will be presenting our poster with QPS Holdings, LLC on the Phase 1B trial of AST-004, and its innovative use of serial CSF collection!
Another milestone for Astrocyte Pharmaceuticals!?We look forward to advancing our neuroprotectant AST-004 to Phase 2 clinical studies in the US! https://lnkd.in/eGk-9Qsk ???#biotech #stroke #tbi #concussion U.S. Army Medical Research and Development Command, MTEC | Medical Technology Enterprise Consortium, BrightFocus Foundation